Patent Assignment
Reel/Frame 033666/0185
Assignment of Assignor's Interest
Recorded: 2014-09-04
Pages: 13
Assignor
GBP IP, LLC
Executed: 2014-08-01
Assignee
MILTENYI BIOTEC TECHNOLOGY, INC
910 CLOPPER ROAD, SUITE 200S, GAITHERSBURG, MARYLAND, 20878
Covered Properties
(18)
Method for Production of High Titer Virus and High Efficiency Retroviral Mediated Transduction of Mammalian Cells
Patent:
5,858,740 →
Application:
08/438,582 →
Method for Production of High Titer Virus and High Efficiency Retroviral Mediated Transduction of Mammalian Cells
Patent:
6,051,427 →
Application:
08/517,488 →
Method and Means for Producing High Titer, Safe, Recombinant Lentivirus Vectors
Patent:
5,994,136 →
Application:
08/989,394 →
Method for Production of High Titer Virus and High Efficiency Retroviral Mediated Transduction of Mammalian Cells
Patent:
6,218,187 →
Application:
09/266,596 →
Method and Means for Producing High Titer, Safe, Recombinant Lentivirus Vectors
Patent:
6,165,782 →
Application:
09/271,365 →
Method and Means for Producing High Titer, Safe, Recombinant Lentivirus Vectors
Patent:
6,428,953 →
Application:
09/604,013 →
Selection System for Generating Efficient Packaging Cells for Lentiviral Vectors
Patent:
6,797,512 →
Application:
09/831,623 →
Method for Production of High Titer Virus and High Efficiency Retroviral Mediated Transduction of Mammalian Cells
Method and Means for Producing High Titer, Safe, Recombinant Lentivirus Vectors
Patent:
7,250,299 →
Application:
10/031,639 →
Lentiviral Vectors Encoding Clotting Factors for Gene Therapy
Method and Means for Producing High Titer, Safe, Recombinant Lentivirus Vectors
Method for Production of High Titer Virus and High Efficiency Retroviral Mediated Transduction of Mammalian Cells
Lentiviral Vector Particles Resistant to Complement Inactivation
Pseudotyped Retroviral Vectors
Liver Specific Transcriptional Enhancer
Method and Means for Producing High Titer, Safe, Recombinant Lentivirus Vectors
Lentiviral Vectors Featuring Liver Specific Transcriptional Enhancer and Methods of Using Same
Method and Means for Producing High Titer, Safe, Recombinant Lentivirus Vectors
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 12, 2001
From: MCGUINNESS, RYAN; NALDINI, LUIGI
To: CELL GENESYS, INC.
Reel/Frame 012182/0636 →
Assignment of Assignor's Interest
Aug 19, 2002
From: MCARTHUR, JAMES G.; TALBOT, DALE JOHN; SIMMONS, ANDREW D.; MCGUINESS, RYAN
To: CELL GENESYS, INC.
Reel/Frame 013214/0493 →
Corrective Assignment to Correct the Execution Date of the 4TH Assignor. Document Previously Recorded at Reel 013214 Frame 0493.
Nov 19, 2002
From: MCARTHUR, JAMES G.; TALBOT, DALE JOHN; SIMMONS, ANDREW D.; MCGUINNESS, RYAN
To: CELL GENESYS, INC.
Reel/Frame 013507/0238 →
Assignment of Assignor's Interest
Oct 24, 2006
From: MCARTHUR, JAMES G.; TALBOT, DALE JOHN; SIMMONS, ANDREW D.; MCGUINNESS, RYAN
To: CELL GENESYS, INC.
Reel/Frame 018429/0238 →
Assignment of Assignor's Interest
Jan 25, 2007
From: MCARTHUR, JAMES G.; TALBOT, DALE JOHN; SIMMONS, ANDREW D.; MCGUINNESS, RYAN
To: CELL GENESYS, INC.
Reel/Frame 018807/0125 →
Assignment of Assignor's Interest
Jul 20, 2007
From: NALDINI, LUIGI; DULL, THOMAS; BUKOVSKY, ANATOLY; FARSON, DEBORAH
To: CELL GENESYS, INC.
Reel/Frame 019585/0952 →
Assignment of Assignor's Interest
Mar 18, 2008
From: CELL GENESYS, INC.
To: GBP IP, LLC
Reel/Frame 020666/0224 →
Assignment of Assignor's Interest
Feb 26, 2018
From: MILTENYI BIOTEC TECHNOLOGY, INC.
To: MILTENYI BIOTEC GMBH
Reel/Frame 045035/0212 →
Assignment of Assignor's Interest
Dec 29, 2019
From: MILTENYI BIOTEC GMBH
To: MILTENYI BIOTEC B.V. & CO. KG
Reel/Frame 051443/0669 →